Serum MicroRNA Expression Profile Distinguishes Enterovirus 71 and Coxsackievirus 16 Infections in Patients with Hand-Foot-and-Mouth Disease
Lunbiao Cui(Jiangsu Provincial Center for Disease Control and Prevention), Hua Wang(Jiangsu Provincial Center for Disease Control and Prevention), Haijing Li(Northeast Agricultural University), Baoli Zhu(Jiangsu Provincial Center for Disease Control and Prevention), Yi‐Wei Tang(Soochow University), Jun Li(Nanjing Children's Hospital), Xian Qi(Peking University), Yan Guo(Institute of Microbiology), Yuhua Qi(Chinese Center For Disease Control and Prevention), Minghao Zhou(Jiangsu Provincial Center for Disease Control and Prevention), Zhiyang Shi, Kangchen Zhao(Jiangsu Provincial Center for Disease Control and Prevention), Yiyue Ge(Jiangsu Provincial Center for Disease Control and Prevention), Xiling Guo(Jiangsu Provincial Center for Disease Control and Prevention), Charles W. Stratton(Vanderbilt University Medical Center)
Cited by 81
Related Papers
Laboratory diagnosis of emerging human coronavirus infections – the state of the art
|Emerging Microbes & Infections|2020|834
Co-infection with respiratory pathogens among COVID-2019 cases
|Virus Research|2020|637
Serum Cytokine and Chemokine Profile in Relation to the Severity of Coronavirus Disease 2019 in China
|The Journal of Infectious Diseases|2020|391
A Family Cluster of Infections by a Newly Recognized Bunyavirus in Eastern China, 2007: Further Evidence of Person-to-Person Transmission
|Clinical Infectious Diseases|2011|268
An integrative drug repositioning framework discovered a potential therapeutic agent targeting COVID-19
|Signal Transduction and Targeted Therapy|2021|204